Impact of ADAM17 Expression as a Potential Prognostic Biomarker and Target for Therapy in Node-Negative Breast Carcinoma

Journal of Cancer and Tumor International
doi 10.9734/jcti/2017/35955
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Sciencedomain International

Related search

CDK1 Serves as a Potential Prognostic Biomarker and Target for Lung Cancer

Journal of International Medical Research
BiochemistryMedicineCell Biology
2020English

Prognostic Influence of Cyclooxygenase-2 Protein and mRNA Expression in Node-Negative Breast Cancer Patients

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Circular RNA Hsa_circ_0078602 May Have Potential as a Prognostic Biomarker for Patients With Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2018English

sCLU as Prognostic Biomarker and Therapeutic Target in Osteosarcoma

Bioengineered
Applied MicrobiologyBiotechnologyMedicineBioengineering
2019English

The PREX1/Rac Signaling Axis: Potential as a Biomarker and Therapeutic Target in Breast Cancer

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2015English

Identification of CELSR2 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

SLC39A6: A Potential Target for Diagnosis and Therapy of Esophageal Carcinoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Biomarker mRNAs as Prognostic Tools for Lymph Node Analysis in Colorectal Cancer

Biomarkers in Medicine
BiochemistryDrug DiscoveryClinical Biochemistry
2019English

HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis

Clinical Cancer Research
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy